SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-18-162665
Filing Date
2018-05-14
Accepted
2018-05-14 16:30:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d588360dsc13d.htm SC 13D 68918
  Complete submission text file 0001193125-18-162665.txt   70565
Mailing Address C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 510-240-6000
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90473 | Film No.: 18831144
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 (908) 947-3120
APHC Holdings, LLC (Filed by) CIK: 0001739290 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D